Evidence map›Paper›PMID 40114417›Full record

ArticleCell biochemistry and function2025

E7HPV16 Oncogene and 17beta-Estradiol Stress, Promotes Oncogenic microRNA Expression Patterns, Cell Proliferation and Cervical Intraepithelial Neoplasia 1.

Erandi Arvizu-Hernandez, Rodolfo Ocadiz-Delgado, Patricio Gariglio

Abstract read
In one paragraph

Article in Cell biochemistry and function, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erandi Arvizu-HernandezDepartment of Genetics and Molecular Biology, Centro deInvestigación y de Estudios Avanzados del IPN, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-9825-7426
Rodolfo Ocadiz-DelgadoDepartment of Genetics and Molecular Biology, Centro deInvestigación y de Estudios Avanzados del IPN, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-4576-881X
Patricio GariglioDepartment of Genetics and Molecular Biology, Centro deInvestigación y de Estudios Avanzados del IPN, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-0024-7076

Funding

This work has been funded by Consejo Nacional de Humanidades, Ciencia y Tecnología (CONAHCYT, Mexico), grant number CF-2023-I-744.
6 · The paper itself

Abstract

Cervical cancer (CC) is the second cause of death by a neoplasia in woman in Mexico. Among the factors that contribute to its development are prolonged infection by a high-risk HPV type and the use of estrogens. It is well known that diagnosis at early stages is extremely important since, in most cases, progression towards carcinogenesis could be prevented, hence the importance of finding candidates that serve as early biomarkers. Several studies have shown that the expression level of the tumor suppressor miR-218 is diminished in CC while oncomiR miR-21 is overexpressed. On the other hand, it has been reported that the Potassium calcium-activated channel subfamily M alpha 1 (Kcnma1) oncogene, a known target gene of miR-218, is overexpressed in CC. However, there are few studies on the expression of this oncogene in Cervical Intraepithelial Neoplasia 1 (CIN 1). In this study, the analysis of the K14E7HPV16 carcinogenesis model in young mice (1.5-month-old), showed that a single-dose of 17β-estradiol (E

Indexed as

EstradiolHuman papillomavirus 16MicroRNAsPapillomavirus E7 ProteinsUterine Cervical DysplasiaUterine Cervical NeoplasmsAnimalsCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMiceEstradiolMicroRNAsoncogene protein E7, Human papillomavirus type 16Papillomavirus E7 ProteinsCIN 1HPVKcnma1miR‐21miR‐218

Identifiers

PMID40114417
PMCPMC11926415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.